Connection
Barry Uretsky to Infusions, Intravenous
This is a "connection" page, showing publications Barry Uretsky has written about Infusions, Intravenous.
|
|
Connection Strength |
|
 |
|
 |
|
0.063 |
|
|
|
-
Huang MH, Wu Y, Nguyen V, Rastogi S, McConnell BK, Wijaya C, Uretsky BF, Poh KK, Tan HC, Fujise K. Heart protection by combination therapy with esmolol and milrinone at late-ischemia and early reperfusion. Cardiovasc Drugs Ther. 2011 Jun; 25(3):223-32.
Score: 0.023
-
Uretsky BF, Verbalis JG, Murali S, Betschart AR, Kolesar JA, Reddy PS. Control of atrial natriuretic peptide secretion in patients with severe congestive heart failure. J Clin Endocrinol Metab. 1990 Jul; 71(1):146-51.
Score: 0.021
-
O'Connor CM, Gattis WA, Uretsky BF, Adams KF, McNulty SE, Grossman SH, McKenna WJ, Zannad F, Swedberg K, Gheorghiade M, Califf RM. Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST). Am Heart J. 1999 Jul; 138(1 Pt 1):78-86.
Score: 0.010
-
Lo MW, Toh J, Emmert SE, Ritter MA, Furtek CI, Lu H, Colucci WS, Uretsky BF, Rucinska E. Pharmacokinetics of intravenous and oral losartan in patients with heart failure. J Clin Pharmacol. 1998 Jun; 38(6):525-32.
Score: 0.009
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|